Author

B. Fox

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Organism:C. elegans· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Artyukhin· 1 shared A. Chaturbedi· 1 shared A. Jones· 1 shared A. Malaney· 1 shared A. N. Newby· 1 shared A. Tauffenberger· 1 shared B. Curtis· 1 shared B. D. Piening· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Artyukhin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evolutionarily related host and microbial pathways regulate fat desaturation

B. Fox, M. Helf, R. Burkhardt, A. Artyukhin, B. Curtis, D. F. Palomino, A. Chaturbedi, A. Tauffenberger, C. J. Wrobel, Y. Zhang, S. S. Lee, F. Schroeder

This study identifies how host and microbial pathways regulate fat desaturation through shared signaling mechanisms in C. elegans.

bioRxiv · Aug 31, 2023Biochemistry

Lipid nanoparticle structure and delivery route during pregnancy dictates mRNA potency, immunogenicity, and health in the mother and offspring

N. Chaudhary, A. N. Newby, M. L. Arral, S. S. Yerneni, S. T. LoPresti, R. Doerfler, D. M. S. Petersen, B. Fox, T. Coon, A. Malaney, Y. Sadovsky, K. A. Whitehead

This study identifies LNP structures that deliver mRNA effectively and safely during pregnancy, showing how their composition affects immunogenicity, maternal organ expression, and offspring health.

bioRxiv · Feb 15, 2023 · PreprintBioengineering

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

D. A. Knorr, R. Leidner, S. Jensen, R. Meng, A. Jones, C. Ballesteros-Merino, R. B. Bell, M. Baez, D. Sprott, C. Bifulco, B. D. Piening, R. Dahan, B. Fox, J. Ravetch

This paper identifies FcyRIIB as an inhibitory Fc receptor limiting Treg depletion by anti-CTLA-4 antibodies and shows Fc engineering can enhance their efficacy.

bioRxiv · Jan 19, 2023 · PreprintImmunology